News
Announcements & corporate materials.
Press releases, corporate materials, and program milestones as we advance therapies for bile acid–mediated disease.
Announcements
Press releases.
Corporate, patent, and program announcements.
- AnnouncementJune 2026
Viscera Labs announces FDA regulatory milestone.
PDF - Patent2023
Viscera Labs announces receipt of issue notification from the USPTO.
PDF - Preclinical2023
Viscera Labs announces the completion of the preclinical evaluation of VL-001.
PDF - Patent2022
Viscera Labs announces receipt of issue notification from the USPTO.
PDF - Preclinical2020
Viscera Labs announces the preclinical investigation of colesevelam targeted delivery.
PDF
Stay informed
Be the first to hear what's next.
For media inquiries, investor materials, or partnership conversations, reach out directly. We'll add you to our distribution list for future announcements.
Get in touch